Effect of hyperbaric oxygen therapy on essential haematuria.
Forty-three patients with essential haematuria were studied for 35 days to determine the efficacy of hyperbaric oxygen (OHP) exposure on haemostatic ability. Out of 15 untreated patients, haematuria persisted for the study period in all but one patient (6.7%). Out of 11 patients who received 90 mg/day of carbazochrome sodium sulfate and 750 mg/day of tranexanic acid excellent haemostatic results had been obtained in 2 (18.2%). Results of exposure of 17 patients to 2 atm. pressure of OHP for 90 min daily were excellent in 10 (58.8%) and good in one (5.9%). No serious adverse effects had been noted following OHP treatment. These results indicate that OHP can be applied for the treatment of essential haematuria if routine haemostatic drugs fail to improve the condition.
Nakada
T
T
Department of Urology, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan.
Sasagawa
I
I
Koike
H
H
Furuta
H
H
Katayama
T
T
Ota
K
K
Chikenji
M
M
Matsushita
T
T
Saito
H
H
D000323:Adrenochrome / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D005260:Female; D006417:Hematuria / Q000628:therapy*; D006489:Hemostatic Techniques; D006801:Humans; D006931:Hyperbaric Oxygenation; D008297:Male; D008875:Middle Aged; D014148:Tranexamic Acid / Q000627:therapeutic use
D014148:Tranexamic Acid; D000323:Adrenochrome